XML 36 R28.htm IDEA: XBRL DOCUMENT v3.25.1
Segment Reporting (Tables)
3 Months Ended
Mar. 31, 2025
Segment Reporting [Abstract]  
Schedule of Segment Loss Including Significant Segment Expenses

The table below is a summary of the segment loss, including significant segment expenses (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2025

 

 

2024

 

Program expenses

 

 

 

 

 

 

 Navacaprant (NMRA-140) program

 

$

(24,493

)

 

$

(24,319

)

 M4 PAM programs

 

 

(2,882

)

 

 

(3,524

)

 NMRA-511 program

 

 

(2,580

)

 

 

(1,887

)

 Preclinical programs

 

 

(1,002

)

 

 

(2,409

)

Research and development personnel-related costs

 

 

(12,326

)

 

 

(10,875

)

General and administrative expense

 

 

(18,785

)

 

 

(14,317

)

Interest income

 

 

3,074

 

 

 

6,365

 

Other segment items(1)

 

 

(8,998

)

 

 

(2,755

)

 Net loss

 

$

(67,992

)

 

$

(53,721

)

(1) Includes other research and development costs, provision for income taxes, and other income (expense).